Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002723943 | SCV003565253 | pathogenic | Inborn genetic diseases | 2021-08-19 | criteria provided, single submitter | clinical testing | The c.3989T>G (p.L1330*) alteration, located in exon 26 (coding exon 26) of the KMT2C gene, consists of a T to G substitution at nucleotide position 3989. This changes the amino acid from a leucine (L) to a stop codon at amino acid position 1330. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |